Travis Steed
BofA Securities, Research Division

Everybody. Travis Steed, first presentation of the afternoon. Welcoming Stryker up. We have Spencer Stiles, President and COO; Jason Beach, VP and Group CFO. What's the division? Make sure I got the name right.

Jason Beach
VP and Group CFO of MedSurg & Neurotechnology

MedSurge & Neurotech.

Travis Steed
BofA Securities, Research Division

MedSurge & NuroTech. Okay. And then Nick Mead, VP of IR, probably one of your first firesides.

Nick Mead
Vice President of Investor Relations

[indiscernible].

Travis Steed
BofA Securities, Research Division

All right. Good. Well, thanks, everybody, for joining us. Spencer, maybe first question for you. As you kind of moved into the COO role, and I'd say you probably have more influence on the Stryker strategy going forward. What do you think kind of changes? What are you doing differently in this kind of bigger picture strategy-wise for Stryker as you have more influence?

Spencer Stiles
President & COO

Super. First off, Travis, thanks for including us. It's been great, and I appreciate the question and the time today with everyone. So high level, nothing really will change. We still love our strategy about leading our markets with innovation, M&A, our specialized businesses that we run. That will still be foundational to our growth strategy in the future.

And our expectations will continue to lead at the high end of med tech and perform at the high end of med tech. So not a lot of day in and